Francesco Ferrara

InstitutionUsl Umbria 1
AddressPerugia
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 35 Covid-19 publications, with a maximum of 5 publications in January 2021
    All Publications
    Bar chart showing 182 publications over 25 distinct years, with a maximum of 20 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Vitiello A, Ferrara F. Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update. Cardiovasc Drugs Ther. 2021 Aug 30. PMID: 34460031.
      Citations:    Fields:    
    2. Vitiello A, Ferrara F. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc Toxicol. 2021 10; 21(10):781-789. PMID: 34255300.
      Citations: 2     Fields:    Translation:HumansAnimals
    3. Ferrara F, Rausei S. Reply to: "A multifaceted virus. Nonreducible and strangulated effects of COVID-19". J Trauma Acute Care Surg. 2021 07 01; 91(1):e34-e35. PMID: 33797483.
      Citations:    Fields:    Translation:Humans
    4. Ferrara F, Vitiello A. The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections. Naunyn Schmiedebergs Arch Pharmacol. 2021 07; 394(7):1589-1593. PMID: 34151392.
      Citations: 4     Fields:    Translation:HumansAnimals
    5. Vitiello A, La Porta R, Troiano V, Ferrara F. COVID-19 vaccination in pregnancy. Drugs Ther Perspect. 2021; 37(7):313-314. PMID: 33976529.
      Citations:    
    6. Vitiello A, Ferrara F. Brief review of the mRNA vaccines COVID-19. Inflammopharmacology. 2021 Jun; 29(3):645-649. PMID: 33932192.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    7. Vitiello A, Ferrara F. Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients. Wien Klin Wochenschr. 2021 09; 133(17-18):983-988. PMID: 33877436.
      Citations: 7     Fields:    Translation:Humans
    8. Ferrara F, Pianesi L, Vitiello A. COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified. Immunol Res. 2021 04; 69(2):115-116. PMID: 33860404.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Ferrara F, Vitiello A. Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance. Cardiovasc Toxicol. 2021 06; 21(6):498-503. PMID: 33835386.
      Citations: 5     Fields:    Translation:Humans
    10. Ferrara F, Vitiello A. The advantages of drug treatment with statins in patients with SARS-CoV-2 infection. Wien Klin Wochenschr. 2021 Sep; 133(17-18):958-965. PMID: 33779831.
      Citations: 3     Fields:    Translation:Humans
    11. Vitiello A, Porta R, Pianesi L, Ferrara F. COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view. Ir J Med Sci. 2022 Feb; 191(1):487-488. PMID: 33710481.
      Citations: 10     Fields:    
    12. Vitiello A, Ferrara F. Anti-fibrotic therapy for the treatment of pulmonary sequelae in patients healed by COVID-19. Lung India. 2021 Mar; 38(Supplement):S129-S130. PMID: 33687000.
      Citations: 5     
    13. Ferrara F, Santilli P, Bartolini L, Vitiello A, Pennacchia A, Di Croce S, D'Aiuto V. [The importance of the logistic warehouse in pandemic period: the experience of the USL Umbria 1 (Perugia, Italy) during covid-19.] Recenti Prog Med. 2021 03; 112(3):219-224. PMID: 33687361.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    14. Vitiello A, Ferrara F. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state. Respir Med. 2021 03; 178:106322. PMID: 33550151.
      Citations: 19     Fields:    Translation:Humans
    15. Vitiello A, Pelliccia C, Ferrara F. Drugs acting on the renin-angiotensin system and SARS-CoV-2. Drug Discov Today. 2021 04; 26(4):870-874. PMID: 33486116.
      Citations: 10     Fields:    Translation:Humans
    16. Vitiello A, La Porta R, D'Aiuto V, Ferrara F. Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade. Hum Immunol. 2021 Apr; 82(4):264-269. PMID: 33632561.
      Citations: 11     Fields:    Translation:Humans
    17. Ferrara F, Vitiello A. Efficacy of synthetic glucocorticoids in COVID-19 endothelites. Naunyn Schmiedebergs Arch Pharmacol. 2021 05; 394(5):1003-1007. PMID: 33443616.
      Citations: 11     Fields:    Translation:Humans
    18. Vitiello A, Ferrara F, Porta R. Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? Ir J Med Sci. 2021 Nov; 190(4):1637-1638. PMID: 33433843.
      Citations: 9     Fields:    Translation:Humans
    19. Vitiello A, La Porta R, Ferrara F. Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19. Med Hypotheses. 2021 Feb; 147:110486. PMID: 33460992.
      Citations: 10     Fields:    Translation:Humans
    20. Vitiello A, La Porta R, Ferrara F. Correlation between the use of statins and COVID-19: what do we know? BMJ Evid Based Med. 2020 Dec 02. PMID: 33268349.
      Citations: 7     Fields:    
    21. Rausei S, Ferrara F, Zurleni T, Frattini F, Chiara O, Pietrabissa A, Sarro G. Dramatic decrease of surgical emergencies during COVID-19 outbreak. J Trauma Acute Care Surg. 2020 12; 89(6):1085-1091. PMID: 32890343.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    22. Vitiello A, Ferrara F. Remdesivir versus ritonavir/lopinavir in COVID-19 patients. Ir J Med Sci. 2021 08; 190(3):1249-1250. PMID: 33206336.
      Citations: 15     Fields:    
    23. Ferrara F, Vitiello A. Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19. Discov Med. 2020 Nov-Dec; 30(161):155-161. PMID: 33593483.
      Citations:    Fields:    Translation:Humans
    24. Vitiello A, Ferrara F. Antidiabetes Agents against Sars-Cov-2 Infection. SN Compr Clin Med. 2020; 2(12):2718-2721. PMID: 33134845.
      Citations: 1     
    25. Ferrara F, Porta R, D'Aiuto V, Vitiello A. Remdesivir and COVID-19. Ir J Med Sci. 2021 08; 190(3):1237-1238. PMID: 33068241.
      Citations: 7     Fields:    
    26. Vitiello A, Ferrara F. Therapeutic Strategies for SARS-CoV-2 acting on ACE-2. Eur J Pharm Sci. 2021 Jan 01; 156:105579. PMID: 33010419.
      Citations: 16     Fields:    Translation:Humans
    27. Vitiello A, Ferrara F. Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19. Life Sci. 2020 Dec 01; 262:118510. PMID: 32991879.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    28. Ferrara F, Porta R, Santilli P, D'Aiuto V, Vitiello A. Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times? Indian J Pharmacol. 2020 Sep-Oct; 52(5):441-442. PMID: 33283779.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    29. Vitiello A, Pelliccia C, Ferrara F. COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy. SN Compr Clin Med. 2020 Aug 27; 1-4. PMID: 32875276.
      Citations: 14     
    30. Pata F, Bondurri A, Ferrara F, Parini D, Rizzo G. Enteral stoma care during the COVID-19 pandemic: practical advice. Colorectal Dis. 2020 Sep; 22(9):985-992. PMID: 32691949.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    31. Vitiello A, La Porta R, Ferrara F. Sacubitril, valsartan and SARS-CoV-2. BMJ Evid Based Med. 2020 Jul 27. PMID: 32719054.
      Citations: 11     Fields:    
    32. Ferrara F, De Rosa F, Vitiello A. The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit. SN Compr Clin Med. 2020; 2(8):1064-1068. PMID: 32838168.
      Citations: 6     
    33. Vitiello A, Ferrara F. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know? Eur J Pharmacol. 2020 Sep 15; 883:173373. PMID: 32679185.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    34. Ferrara F, Granata G, Pelliccia C, La Porta R, Vitiello A. The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection? Eur J Clin Pharmacol. 2020 Nov; 76(11):1615-1618. PMID: 32594204.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
    35. Ferrara F, De Rosa F, Vitiello A. Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? SN Compr Clin Med. 2020 Jun 26; 1-2. PMID: 32838149.
      Citations:    
    Ferrara's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (274)
    Explore
    _
    Co-Authors (34)
    Explore
    _
    Similar People (60)
    Explore
    _